(-0.15%) 5 139.50 points
(-0.11%) 38 515 points
(-0.08%) 17 891 points
(-0.36%) $82.33
(1.67%) $2.06
(-1.04%) $2 333.20
(-2.28%) $27.03
(-0.71%) $954.70
(0.24%) $0.935
(0.47%) $11.03
(0.23%) $0.798
(-0.13%) $93.18
Live Chart Being Loaded With Signals
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain...
Stats | |
---|---|
Dagens volum | 240 995 |
Gjennomsnittsvolum | 138 824 |
Markedsverdi | 14.58M |
EPS | $0 ( 2024-04-04 ) |
Neste inntjeningsdato | ( $0 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.313 |
ATR14 | $0.0740 (8.03%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-15 | Nantahala Capital Management, Llc | Buy | 0 | Common Stock |
2023-07-20 | Nantahala Capital Management, Llc | Buy | 2 205 883 | 2023 Series A Warrants |
2023-07-20 | Nantahala Capital Management, Llc | Buy | 2 205 883 | 2023 Series B Warrants |
2023-07-20 | Nantahala Capital Management, Llc | Buy | 750 883 | 2023 Pre-Funded Warrants |
2024-03-15 | Nantahala Capital Management, Llc | Buy | 755 000 | Call Option (Right to Buy) |
INSIDER POWER |
---|
82.92 |
Last 92 transactions |
Buy: 3 436 001 | Sell: 171 828 |
Volum Korrelasjon
AcelRx Pharmaceuticals Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
NAKD | 0.974 |
TNGX | 0.964 |
UTHR | 0.952 |
IMV | 0.941 |
WTBA | 0.94 |
AVIR | 0.939 |
UK | 0.937 |
APM | 0.936 |
BFRI | 0.935 |
GRNA | 0.934 |
10 Mest negative korrelasjoner | |
---|---|
PDFS | -0.956 |
IDCC | -0.956 |
ALTR | -0.956 |
ANSS | -0.954 |
LPTH | -0.953 |
INTA | -0.952 |
SLMBP | -0.952 |
APXI | -0.952 |
SJ | -0.952 |
NCAC | -0.951 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
AcelRx Pharmaceuticals Korrelasjon - Valuta/Råvare
AcelRx Pharmaceuticals Økonomi
Annual | 2023 |
Omsetning: | $651 000 |
Bruttogevinst: | $651 000 (100.00 %) |
EPS: | $-0.000700 |
FY | 2023 |
Omsetning: | $651 000 |
Bruttogevinst: | $651 000 (100.00 %) |
EPS: | $-0.000700 |
FY | 2022 |
Omsetning: | $1.77M |
Bruttogevinst: | $-820 000 (-46.30 %) |
EPS: | $5.73 |
FY | 2021 |
Omsetning: | $2.82M |
Bruttogevinst: | $-935 000 (-33.18 %) |
EPS: | $-5.86 |
Financial Reports:
No articles found.
AcelRx Pharmaceuticals
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain; ARX-02, which is in Phase 2 clinical trial for the treatment of cancer breakthrough pain in opioid-tolerant patients; and 4ARX-03 for mild sedation and pain relief during painful procedures. Its product candidates also include Niyad, a regional anticoagulant for the extracorporeal circuit; and LTX-608, a nafamostat formulation for direct IV infusion being explored as an investigational product for antiviral treatment of COVID, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was incorporated in 2005 and is based in Hayward, California.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.